Erlotinib Improves the Response of Glioblastoma Cells Resistant to Photodynamic Therapy.Published in:Brain Sciences (2076-3425), 2024, v. 14, n. 12, p. 1192, doi. 10.3390/brainsci14121192By:Olthoff, Karen;Nigra, Ayelén D.;Milla Sanabria, Laura N.Publication type:Article